 |
| Actos |
The French drug safety to suspend the application of medicine against the best-selling diabetes pill and called Competact Takeda Actos with metformin, the investigation by the office of the French public health insurance has highlight the risks of drugs for cancer of the bladder. [ID: nLDE758246]
Robert Spanheim, vice president of medical and scientific affairs of the Japanese pharmaceutical company, said the company has not yet had time to examine the French study and its conclusions.
But he said other studies, including two ongoing prospective studies conducted by the health insurer Kaiser Permanente, have so far shown no risk to patients of bladder cancer or other cancers Actos. (Reporting by Ransdell Pierson, edited by Gerald E. McCormick)
Robert Spanheim, vice president of medical and scientific affairs of the Japanese pharmaceutical company, said the company has not yet had time to examine the French study and its conclusions.
But he said other studies, including two ongoing prospective studies conducted by the health insurer Kaiser Permanente, have so far shown no risk to patients of bladder cancer or other cancers Actos. (Reporting by Ransdell Pierson, edited by Gerald E. McCormick)
0 comments:
Post a Comment
We will be very pleased to have your comments and appreciate your views, suggestions, likes, dislikes etc...